首页> 外文期刊>Annals of surgical oncology >External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
【24h】

External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.

机译:颈外静脉切开术作为一种有用的选择,支持选择完全植入式进入装置放置的头静脉。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Cephalic vein (CV) cut down for totally implantable venous access device (TIVAD) placement has been accepted as an alternative to the percutaneous subclavian vein approach. The aim of this retrospective study was to validate the external jugular vein (EJV) cut-down approach when the CV is not feasible. METHODS: Patients receiving a TIVAD from January 1995 to December 2003 were included in this study. Age, sex, surgical technique, disease, device used, length of the procedure, and morbidity were considered. RESULTS: A total of 427 TIVADs were placed in 425 patients: 253 men (59.5%) and 172 women (40.5%) aged 31 to 79 years. Of 425 patients, 5 were excluded; 420 underwent a CV cut down on the first attempt, and 391 (93.1%) procedures were successful. Among the final 29 patients, 20 (68.96%) underwent a TIVAD placement through the ipsilateral EJV cut-down approach. In the remaining nine patients (31.04%), TIVAD placement was performed through the ipsilateral internal jugular vein in four cases, via the ipsilateral axillary vein in three cases, and through the ipsilateral coracobrachial vein in the other cases. No immediate postoperative complications were detected in any of the patients. CONCLUSIONS: TIVAD placement by the CV cut-down approach is safe and fast, and its success rate is very high. By avoiding the immediate complications associated with the percutaneous approach, the EJV cut down has to be considered a valid, safe, and suitable alternative when the CV is not feasible.
机译:背景:为完全植入式静脉通路装置(TIVAD)放置而切掉的颈静脉(CV)已被接受作为经皮锁骨下静脉入路的替代选择。这项回顾性研究的目的是在不可行CV时验证颈外静脉切开术。方法:本研究纳入了1995年1月至2003年12月接受TIVAD治疗的患者。考虑年龄,性别,手术技术,疾病,使用的器械,手术时间和发病率。结果:425例患者中共放置了427例TIVAD:年龄在31至79岁之间的253例男性(59.5%)和172例女性(40.5%)。在425名患者中,有5名被排除在外;首次尝试进行CV减少了420,成功完成了391(93.1%)个步骤。在最后的29名患者中,有20名(68.96%)通过同侧EJV切开术接受了TIVAD植入。在其余9例患者中(31.04%),TIVAD植入是通过四例同侧颈内静脉进行的,三例是通过同侧腋静脉进行的,其他情况下是通过同侧胸臂肱静脉进行的。在任何患者中均未发现术后立即并发症。结论:通过CV降低法放置TIVAD是安全且快速的,其成功率很高。通过避免与经皮入路相关的直接并发症,当CV不可行时,EJV切开术必须被认为是一种有效,安全且合适的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号